Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

76
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

582
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

302
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
302
Lipid Absorption01:24

Lipid Absorption

3.5K
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
3.5K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

1.9K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision Medicine for Lipids: The New US Guidelines for Dyslipidemia.

Clinical chemistry·2026
Same author

Establishment and functional analysis of an inducible Apoc2-knockout mouse model to investigate the role of Apoc2 in normal hematopoiesis.

Lab animal·2026
Same author

Measurement of low-density lipoprotein cholesterol and other circulating lipids in Brazil: a systematic literature review.

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

High-Density Lipoprotein-Specific Phospholipid Efflux (HDL-SPE) Assay in Mice.

Molecular nutrition & food research·2026
Same author

In Reply to Inter-Instrument Imprecision Complements Bias in Evaluating LDL-C Method Performance.

Clinical chemistry·2026
Same author

Corrigendum to "Identification of a novel apoB variant in a family exhibiting hypocholesterolemia: Mechanistic insights" [J Clin Lipidol (2026) S1933-2874(26)00045-0, ahead of print].

Journal of clinical lipidology·2026

Related Experiment Video

Updated: Mar 29, 2026

Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation
08:24

Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation

Published on: May 22, 2017

8.9K

High-density lipoprotein mimetics: promises and challenges.

Dmitri Sviridov1, Alan T Remaley2

  • 1Laboratory of Lipoproteins and Atherosclerosis, Baker IDI Heart and Diabetes Institute, Melbourne, VIC 3004, Australia Dmitri.Sviridov@bakeridi.edu.au.

The Biochemical Journal
|November 29, 2015
PubMed
Summary

Lipoprotein mimetics are versatile designer molecules, not just for high-density lipoprotein (HDL) functions, but with broad medical and biological applications. This review explores their design, mechanisms, and therapeutic potential in various studies.

Keywords:
apolipoproteinsatherosclerosischolesterol metabolismlipoprotein metabolismpeptides

More Related Videos

Formulation and Characterization of Bioactive Agent Containing Nanodisks
07:58

Formulation and Characterization of Bioactive Agent Containing Nanodisks

Published on: March 17, 2023

1.8K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Related Experiment Videos

Last Updated: Mar 29, 2026

Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation
08:24

Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation

Published on: May 22, 2017

8.9K
Formulation and Characterization of Bioactive Agent Containing Nanodisks
07:58

Formulation and Characterization of Bioactive Agent Containing Nanodisks

Published on: March 17, 2023

1.8K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Area of Science:

  • Biochemistry and Molecular Biology
  • Cardiovascular Disease Research
  • Drug Discovery and Development

Background:

  • Lipoprotein mimetics have been developed over the past 30 years.
  • Initial designs focused on mimicking high-density lipoprotein (HDL) functions for cardiovascular disease.
  • The scope of lipoprotein mimetics extends beyond cardiovascular applications.

Purpose of the Study:

  • To review the fundamental design principles of lipoprotein mimetics.
  • To discuss the mechanisms of action for these engineered molecules.
  • To explore their medical indications and efficacy across preclinical and clinical studies.

Main Methods:

  • Comprehensive literature review of lipoprotein mimetic research.
  • Analysis of design strategies and functional characterization.
  • Evaluation of data from animal models and human clinical trials.

Main Results:

  • Lipoprotein mimetics offer a flexible design concept with diverse applications.
  • Their utility spans beyond correcting lipoprotein metabolism deficiencies.
  • Evidence from studies demonstrates potential in various medical and biological fields.

Conclusions:

  • Lipoprotein mimetics represent a powerful, adaptable platform in medicine and biology.
  • Their design principles and mechanisms warrant further investigation for novel therapeutic strategies.
  • The broad applicability highlights their significance in advancing scientific understanding and treatment options.